12.04.14
Deerland Enzymes, Kennesaw, GA, has received a notice of acceptance from Health Canada Natural and Non-prescription Health Products Directorate (NNHPD) for a Foreign Site Reference Number (FSRN).
Deerland Enzymes is among a select group of companies located in the U.S. chosen to participate in the NNHPD’s pilot program that aims to replace the current foreign site application process with an onsite, third party audit. The company’s quality system was audited earlier in the year, and was assessed by the NNHPD against Canadian Natural Health Products Good Manufacturing Practices (NHP GMP) requirements. As a result, Deerland Enzymes was found to be in compliance as an approved foreign manufacturer, packager and labeler.
“We are extremely appreciative to NNHPD for allowing Deerland to participate and for the manner in which the program was implemented. The FSRN assures our customers that the products we manufacture for them meet the GMP requirements for import and sale in Canada,” said Hope Hanley, Deerland Enzymes’ vice president of quality assurance and regulatory affairs. “This new program of onsite audits for certification expedites the approval process, which is a huge benefit and time savings for our customers who sell products in Canada.”
Deerland Enzymes is among a select group of companies located in the U.S. chosen to participate in the NNHPD’s pilot program that aims to replace the current foreign site application process with an onsite, third party audit. The company’s quality system was audited earlier in the year, and was assessed by the NNHPD against Canadian Natural Health Products Good Manufacturing Practices (NHP GMP) requirements. As a result, Deerland Enzymes was found to be in compliance as an approved foreign manufacturer, packager and labeler.
“We are extremely appreciative to NNHPD for allowing Deerland to participate and for the manner in which the program was implemented. The FSRN assures our customers that the products we manufacture for them meet the GMP requirements for import and sale in Canada,” said Hope Hanley, Deerland Enzymes’ vice president of quality assurance and regulatory affairs. “This new program of onsite audits for certification expedites the approval process, which is a huge benefit and time savings for our customers who sell products in Canada.”
